Genomic analysis of small renal masses reveals mutations linked with renal cell carcinoma and fast-growing tumors
Genomic biomarkers may improve risk stratification and management of patients with SRMs, however a more extensive genomic analysis of SRMs is still needed.
Authors
- Rasa Sabaliauskaitė (ORCID: https://orcid.org/0000-0002-3465-3558)
- Algirdas Žalimas
- Mantas Trakymas
- Sonata Jarmalaitė (ORCID: https://orcid.org/0000-0003-3719-0891)
- Kristina Žukauskaitė (ORCID: https://orcid.org/0000-0002-8707-6598)
- Ieva Vaicekauskaitė (ORCID: https://orcid.org/0000-0003-3536-4384)
- Jurgita Ušinskienė (ORCID: https://orcid.org/0000-0002-9741-2065)
Institutions
- Vilnius University (LT)
- National Cancer Institute (LT)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1007/s00432-025-06162-5
- Citations
- 3
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04